Trial · NCT02258542
Participant flow20
How many started, completed or left each group, period by period.
1 to 20 of 20
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | SIROCCO/CALIMA - Benralizumab 30 mg q.4 Weeks | 953 | |
| Overall Study | STARTED | SIROCCO/CALIMA - Benralizumab 30 mg q.8 Weeks | 973 | |
| Overall Study | STARTED | ZONDA - Benralizumab 30 mg q.4 Weeks | 100 | |
| Overall Study | STARTED | ZONDA - Benralizumab 30 mg q.8 Weeks | 97 | |
| Overall Study | Treated | SIROCCO/CALIMA - Benralizumab 30 mg q.4 Weeks | 953 | |
| Overall Study | Treated | SIROCCO/CALIMA - Benralizumab 30 mg q.8 Weeks | 971 | |
| Overall Study | Treated | ZONDA - Benralizumab 30 mg q.4 Weeks | 100 | |
| Overall Study | Treated | ZONDA - Benralizumab 30 mg q.8 Weeks | 97 | |
| Overall Study | Adolescents Only | SIROCCO/CALIMA - Benralizumab 30 mg q.4 Weeks | 25 | |
| Overall Study | Adolescents Only | SIROCCO/CALIMA - Benralizumab 30 mg q.8 Weeks | 61 | |
| Overall Study | Adolescents Only | ZONDA - Benralizumab 30 mg q.4 Weeks | 0 | |
| Overall Study | Adolescents Only | ZONDA - Benralizumab 30 mg q.8 Weeks | 0 | |
| Overall Study | COMPLETED | SIROCCO/CALIMA - Benralizumab 30 mg q.4 Weeks | 911 | |
| Overall Study | COMPLETED | SIROCCO/CALIMA - Benralizumab 30 mg q.8 Weeks | 924 | |
| Overall Study | COMPLETED | ZONDA - Benralizumab 30 mg q.4 Weeks | 92 | |
| Overall Study | COMPLETED | ZONDA - Benralizumab 30 mg q.8 Weeks | 92 | |
| Overall Study | NOT COMPLETED | SIROCCO/CALIMA - Benralizumab 30 mg q.4 Weeks | 42 | |
| Overall Study | NOT COMPLETED | SIROCCO/CALIMA - Benralizumab 30 mg q.8 Weeks | 49 | |
| Overall Study | NOT COMPLETED | ZONDA - Benralizumab 30 mg q.4 Weeks | 8 | |
| Overall Study | NOT COMPLETED | ZONDA - Benralizumab 30 mg q.8 Weeks | 5 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02258542/flow